ResMed Inc. recently shared highlights from its fiscal 2025 performance, focusing on its strategy for 2030. The company reported a revenue of $5.1 billion with an operating margin of 33% GAAP and 34% Non-GAAP. ResMed serves over 140 countries and employs more than 10,000 people. Their revenue by business is divided among Devices, Masks & Other, and Residential Care Software $(RCS)$, while regional revenue is primarily from the U.S., Canada, and Latin America. The company's focus areas include enhancing patient experience through innovative solutions for Sleep Apnea, improving outcomes for COPD patients, and providing residential care software solutions. ResMed aims to empower 500 million lives by 2030 and has already impacted over 154 million lives with its digital health products and cloud-based software solutions in the past year. You can access the full presentation through the link below.